A novel agonist of the type 1 lysophosphatidic acid receptor (LPA1), UCM-05194, shows efficacy in neuropathic pain amelioration

Gonzalez Gil, I.; Zian, D.; Vazquez-Villa, H.; Hernandez-Torres, G.; Martinez, R. F.; Khiar-Fernandez, N.; Rivera, R.; Kihara, Y.; Devesa, I.; Mathivanan, S.; Rosell del Valle, C.; Zambrana-Infantes, E.; Puigdomenech, M.; Cincilla, G.; Sanchez-Martinez, M.; Rodriguez de Fonseca, F.; Ferrer-Montiel, A.; Chun, J.; Lopez-Vales, R.; Lopez-Rodriguez, M. L.; Ortega-Gutierrez, S.; J. med. Chem., 2019, accepted manuscript

Link to article